
NovoCure Limited NVCR
$ 11.43
-3.3%
Annual report 2025
added 02-26-2026
Country |
|
IPO year |
2015 |
Industry |
Health care |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
111 M |
Market Cap[1] |
$ 1.27 B |
EBITDA (LTM) |
$ -131 M |
P/E (LTM) |
-9.38 |
P/S (LTM) |
2.13 |
EPS (LTM) |
-1.26 |
Other stocks of industry "Health care"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Anthem
ANTM
|
- | -2.32 % | $ 107 B | NYSE,SPB | ||
|
Molina Healthcare
MOH
|
$ 140.67 | 3.99 % | $ 7.43 B | NYSE,SPB | ||
|
Triple-S Management Corporation
GTS
|
- | 0.28 % | $ 847 M | NYSE | ||
|
Magellan Health, Inc.
MGLN
|
- | -0.19 % | $ 2.49 B | Nasdaq Global Select Market,SPB | ||
|
CVS Health Corporation
CVS
|
$ 73.06 | 2.48 % | $ 92.6 B | NYSE,SPB | ||
|
UnitedHealth Group Inc.
UNH
|
$ 271.44 | 0.7 % | $ 246 B | NYSE,SPB | ||
|
Humana
HUM
|
$ 172.41 | 1.33 % | $ 20.8 B | NYSE,SPB | ||
|
Cigna Corporation
CI
|
$ 265.6 | 1.57 % | $ 70 B | NYSE,SPB | ||
|
Centene Corporation
CNC
|
$ 32.72 | -0.29 % | $ 16.1 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.